The Boston-based biotech is axing Phase II plans for its only clinical-stage asset, in a bid to maximise shareholder value.

Helex has raised $3.5m in a seed funding round spearheaded by pi Ventures to advance non-viral gene therapies for kidney ...

Mounjaro generated sales of $6.5bn in Q3 2025, up 109% from the same period in 2024. Zepbound exhibited even higher growth – ...

Epioxa by Glaukos Corp received US Food and Drug Administration (FDA) approval on 20 October as the first and only ...

As healthcare systems work towards new sustainability goals, medical textiles have become a key focus for innovation.

The FDA's draft guidance is supposed to cut the cost and time-associated burden of biosimilar development, despite a mixed ...

Novartis has signed an agreement for the acquisition of all the outstanding shares of US-based Avidity Biosciences.

GSK has acquired the rights to Syndivia’s preclinical antibody drug conjugate (ADC), which is in development for prostate ...

Eli Lilly and NVIDIA will build a new supercomputer to accelerate drug discovery and shorten development cycles.

MSD has received US FDA approval for an updated indication of Winrevair by injection to treat adults with pulmonary arterial ...

Eli Lilly will invest over $1.2bn into its manufacturing site in Puerto Rico, as it aims to assemble a robust supply chain ...